Tutorials › Quantitative Systems Pharmacology (QSP) › Biphasic Viral Decline and Long-Lived Infected Cells

Infectious Disease and Viral Dynamics · Tutorial 393 of 799

Biphasic Viral Decline and Long-Lived Infected Cells

Learn how distinct infected-cell lifespans generate fast and slow viral-decline phases, and how production and clearance shape the observed curve.

Advanced 11 min read

What You'll Learn

  • Formulate a post-treatment model with short- and long-lived infected-cell populations.
  • Derive the viral-load response and the conditions under which it is approximately biexponential.
  • Relate each decline phase to cell loss rates and viral production amplitudes.
  • Calculate a phase crossover and the instantaneous log-slope of total viral load.
  • Recognize when a slow phase may be hidden or when a two-phase interpretation is not justified.
  • Distinguish viral-load curve features from quantities that require additional data to identify.

Why Viral Decline Can Have Two Phases

After an effective antiviral intervention, viral load may decline rapidly at first and then more slowly. One mechanistic explanation is that the intervention greatly reduces the generation of newly infected cells, while already infected cells continue to produce virus as they are lost. If the productively infected population contains groups with different lifespans, the short-lived group can dominate the early decline and the longer-lived group the later decline.

This is a mechanistic interpretation, not a conclusion that follows from curve shape alone. A biphasic curve is compatible with multiple processes; here the model isolates how different infected-cell survival rates and production rates can produce two phases. The earlier material on early viral decline slopes distinguishes observed slopes from the biological quantities they may reflect.

Definition: A biphasic viral-load decline is a decline with two distinguishable temporal components, often a relatively rapid early phase followed by a slower phase. In a two-population infected-cell model, the phases arise because infected populations with different loss rates contribute different amounts of virus over time.

A Two-Population Model

Let \(I_f(t)\) and \(I_s(t)\) denote short-lived and long-lived productively infected cells per millilitre at time \(t\), respectively. Let \(V(t)\) be free-virus concentration in copies per millilitre. The loss rates of the two infected-cell populations are \(\delta_f\) and \(\delta_s\), in inverse days, with \(\delta_f>\delta_s>0\). Each cell population produces virus at constant rates \(p_f\) and \(p_s\), in copies per cell per day. Free virus is cleared at rate \(c\), in inverse days.

$$ \frac{dI_f}{dt}=-\delta_f I_f,\qquad \frac{dI_s}{dt}=-\delta_s I_s,\qquad \frac{dV}{dt}=p_f I_f+p_s I_s-cV. $$

The interpretation requires specific assumptions. Over the interval being modelled, new infection is negligible, for example because treatment has strongly suppressed infection of additional target cells. The infected-cell loss and production rates and the free-virus clearance rate are constant. The two infected-cell groups are treated as distinct, well-mixed populations, and there are no additional changing sources or sinks of virus in this model. These assumptions are simplifications, not universal properties of treated infections.

Solving the first two equations gives \(I_f(t)=I_f(0)e^{-\delta_f t}\) and \(I_s(t)=I_s(0)e^{-\delta_s t}\). Thus, the production from each group declines at that group’s cell-loss rate, provided its per-cell production remains constant. The virus concentration responds to both changing production and viral clearance.

From Infected-Cell Survival to Viral Load

The exact solution for free virus, when \(c\ne\delta_f\) and \(c\ne\delta_s\), is

$$ V(t)=V(0)e^{-ct} +\frac{p_f I_f(0)}{c-\delta_f}\left(e^{-\delta_f t}-e^{-ct}\right) +\frac{p_s I_s(0)}{c-\delta_s}\left(e^{-\delta_s t}-e^{-ct}\right). $$

This expression shows that viral clearance can contribute a transient with rate \(c\). If clearance is much faster than the infected-cell changes, that transient typically fades quickly. After it has faded, the viral concentration is often well approximated by the sum of two exponentials:

$$ V(t)\approx A_f e^{-\delta_f t}+A_s e^{-\delta_s t}, \qquad A_f\approx\frac{p_f I_f(0)}{c},\qquad A_s\approx\frac{p_s I_s(0)}{c}. $$

This approximation requires \(c\) to be substantially larger than both cell-loss rates and the observation interval to extend beyond the initial viral-clearance transient. The amplitudes \(A_f\) and \(A_s\), in copies per millilitre, reflect both the initial number of cells and their per-cell production. They are not simply cell counts.

Result: Under the stated assumptions and after the fast free-virus transient, the observed load is approximately a sum of a fast and a slow exponential. The fast component has log-slope \(-\delta_f\), and the slow component has log-slope \(-\delta_s\). The total load does not in general have one constant log-slope.

Worked Examples

Worked Example: Calculating the Load During the Early Decline

Suppose a hypothetical model has \(A_f=10{,}000\) copies/mL, \(A_s=1{,}005.0252\) copies/mL, \(\delta_f=1.00\) per day, and \(\delta_s=0.0500\) per day. Assume viral clearance is fast enough for the biexponential approximation to apply. Calculate the load at day 1.

Substitute \(t=1\) day into the component model:

$$ V(1)\approx 10{,}000e^{-1.00}+1{,}005.0252e^{-0.0500}. $$

The fast component is \(10{,}000e^{-1.00}\approx3{,}678.79\) copies/mL. The slow component is \(1{,}005.0252e^{-0.0500}\approx956.0095\) copies/mL. Therefore,

$$ V(1)\approx3{,}678.79+956.01=4{,}634.80\ \text{copies/mL}. $$

At day 1 the fast component is still larger, but the slow component contributes almost 956 copies/mL. A single fast exponential would therefore understate the remaining load in this example.

Worked Example: Finding the Crossover and the Total Log-Slope

Consider a hypothetical biexponential load with \(A_f=8{,}000\) copies/mL, \(A_s=2{,}000\) copies/mL, \(\delta_f=0.700\) per day, and \(\delta_s=0.0350\) per day. The two component loads are equal when \(A_f e^{-\delta_f t}=A_s e^{-\delta_s t}\). Solving gives

$$ t_{\mathrm{cross}}= \frac{\ln(A_f/A_s)}{\delta_f-\delta_s} =\frac{\ln(8{,}000/2{,}000)}{0.700-0.0350} =\frac{\ln(4)}{0.665} \approx2.085\ \text{days}. $$

At day 2, the fast component is \(8{,}000e^{-1.40}\approx1{,}972.78\) copies/mL, and the slow component is \(2{,}000e^{-0.0700}\approx1{,}864.79\) copies/mL. Thus,

$$ V(2)\approx1{,}972.7757+1{,}864.7876 =3{,}837.5633\approx3{,}837.56\ \text{copies/mL}. $$

To see why the total slope changes, differentiate the logarithm of the sum. For \(V=A_f e^{-\delta_f t}+A_s e^{-\delta_s t}\),

$$ -\frac{d\ln V}{dt} = \frac{\delta_f A_f e^{-\delta_f t}+\delta_s A_s e^{-\delta_s t}} {A_f e^{-\delta_f t}+A_s e^{-\delta_s t}}. $$

At day 2, substitution gives \((0.700\times1{,}972.78+0.0350\times1{,}864.79)/3{,}837.56\approx0.3769\) per day. This positive quantity is the magnitude of the decline rate on a natural-log scale; the log-slope itself is approximately \(-0.3769\) per day. It lies between the component rates because it is a weighted average of them.

Worked Example: How Production Changes the Phase Amplitudes

Suppose, hypothetically, \(c=8.00\) per day, \(I_f(0)=500\) cells/mL, \(p_f=160\) copies per cell per day, \(I_s(0)=200\) cells/mL, and \(p_s=40\) copies per cell per day. Let \(\delta_f=0.800\) per day and \(\delta_s=0.0400\) per day. Since \(c\) is ten times \(\delta_f\) and 200 times \(\delta_s\), the fast-clearance approximation is plausible after its brief transient.

The approximate amplitudes are the production rates per volume divided by viral clearance:

$$ A_f\approx\frac{p_f I_f(0)}{c} =\frac{160\times500}{8.00}=10{,}000\ \text{copies/mL}, \qquad A_s\approx\frac{p_s I_s(0)}{c} =\frac{40\times200}{8.00}=1{,}000\ \text{copies/mL}. $$

The short-lived group begins with 2.5 times as many cells, but its per-cell production is four times higher. Its viral-load amplitude is therefore ten times the slow group’s amplitude. The crossover is

$$ t_{\mathrm{cross}}= \frac{\ln(10)}{0.800-0.0400} \approx3.03\ \text{days}. $$

If per-cell production had instead been equal in the two groups, the initial amplitude ratio would be the cell-number ratio, 2.5, and the crossover would occur at \(\ln(2.5)/0.760\approx1.21\) days. This comparison shows that cell survival determines component decay rates, while production and initial cell abundance jointly determine how visible and how prolonged each phase is.

Why the Apparent Slope Changes

The total log-slope is the negative weighted average of the two cell-loss rates, with weights equal to the components’ current contributions to viral load. Early in the decline, the fast component may dominate, so the total slope is close to \(-\delta_f\). As that component disappears more quickly, the slow component can dominate and the slope approaches \(-\delta_s\). At the exact crossover, the components have equal load, so the total log-slope is \(-(\delta_f+\delta_s)/2\).

The crossover time exists at a positive value when the initial fast amplitude exceeds the slow amplitude and \(\delta_f>\delta_s\). In general it is given by

$$ t_{\mathrm{cross}}= \frac{\ln(A_f/A_s)}{\delta_f-\delta_s}. $$

A small slow amplitude can postpone the crossover substantially or place it beyond the observation period. Conversely, a sizeable slow amplitude can make the slower component apparent relatively early. The word “phase” describes the dominant contribution over an interval; it does not mean the system switches abruptly from one cell population to another.

Diagnostics, Alternatives, and Limitations

A two-component model is most credible when the data cover enough time to show a reproducible change in slope, measurements are sufficiently frequent and precise to distinguish that change from noise, and the assumed treatment interval is consistent with strongly suppressed new infection. On a log-scale plot, a single exponential appears approximately straight; systematic curvature toward a shallower late slope is consistent with a second, slower component. It is not proof of that mechanism.

Compare the principal modelling choices:

ApproachWhat it representsKey limitation
Single exponentialOne dominant effective decline rateCannot represent a distinct slower component over a broad interval
Biexponential approximationTwo components with separate amplitudes and loss ratesCurve fit alone does not establish two biological cell populations
Explicit virus-clearance modelInfected-cell production together with free-virus clearanceRequires assumptions or data sufficient to distinguish clearance from cell-loss dynamics

A common failure mode is to infer the lifespan of a particular cell population directly from one observed slope. The approximation links component slopes to cell-loss rates only if the assumptions hold and that component dominates the measured load. The observed total slope may be between rates, and a rapid viral-clearance transient can further affect early observations.

Another limitation is identifiability. In the approximate model, viral-load data primarily inform the amplitudes \(A_f\) and \(A_s\), not \(I_f(0)\) and \(p_f\) separately, or \(I_s(0)\) and \(p_s\) separately. A larger cell population with lower production per cell can yield the same amplitude as a smaller population with higher production. Additional measurements or justified constraints are needed to separate those quantities.

The two-population model also assumes constant production and cell-loss rates. If those rates change, or if the infection is not sufficiently suppressed to make new infection negligible, a two-exponential fit may summarize the curve without accurately describing its mechanism. The relevant diagnostic is not just whether a fitted curve looks smooth, but whether its assumptions and predicted component behaviour are credible for the interval studied.

Key takeaway: In the fast-clearance approximation, short- and long-lived infected cells contribute exponentials with different loss rates. The observed phases depend on both those rates and each population’s production-weighted amplitude; viral-load slopes alone do not uniquely identify cell number or per-cell production.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. If \(A_f=6{,}000\) copies/mL, \(A_s=1{,}500\) copies/mL, \(\delta_f=0.600\) per day, and \(\delta_s=0.100\) per day, find the crossover time.
  2. At a time when the fast and slow components contribute 300 and 700 copies/mL, respectively, with rates \(0.800\) and \(0.0500\) per day, calculate the magnitude of the total natural-log decline rate.
  3. Why can two populations with different cell numbers produce equal viral-load amplitudes?
  4. State one reason the earliest observed viral decline may not equal the short-lived infected-cell loss rate.

Solutions. (1) \(t_{\mathrm{cross}}=\ln(6{,}000/1{,}500)/(0.600-0.100)=\ln(4)/0.500\approx2.77\) days. (2) The weighted rate is \((0.800\times300+0.0500\times700)/(300+700)=275/1{,}000=0.275\) per day; the natural-log slope is \(-0.275\) per day. (3) The amplitude depends on both cell abundance and per-cell production, approximately \(pI(0)/c\), so different combinations can give the same value. (4) Free-virus clearance can create an early transient, and the total load may also contain contributions from both infected-cell populations.

Clinical Biostats